Wegovy is the Model of semaglutide that is intended additional for weight loss. Novo Nordisk noted at the end of December that there was comprehensive availability of all doses of Wegovy for pharmacies nationwide. This was following months of "unprecented" demand for Wegovy asRybelsus and copyright brought on thyroid tumors in mice and rats in the